Senior Manager, R&D Quality Assurance

Alnylam

Maidenhead

Hybrid

GBP 95,000 - 130,000

Full time

2 days ago
Be an early applicant

A complete application in a minute

Tailored resume and cover letter, ready to send.

Get past ATS filters

Job summary

Alnylam Pharmaceuticals is seeking a Senior Manager, R&D Quality Assurance who will independently lead the R&D QA Program Lead role for assigned clinical studies, ensuring QA oversight in line with GCP and global regulations. The role includes guiding junior staff and driving improvements while collaborating across study teams, vendors, and external partners.

This hybrid position can be based in Maidenhead, UK (three days onsite) or from other eligible sites, with a focus on audits, inspections,

Qualifications

  • Bachelor's degree in life science or equivalent clinical research experience.
  • Seven years' experience in GCP Quality Assurance or similar.
  • Experience overseeing late phase clinical trials.
  • Experience leading audits and inspection readiness.
  • Experience with QA functions across Clinical Operations, Regulatory Affairs, Data Management, and Safety.

Responsibilities

  • Independently perform the R&D QA Program Lead role for assigned clinical studies with oversight per GCP and regulations.
  • Provide quality oversight for identified studies, mitigate risks and support CAPAs.
  • Lead and support GCP audits ( Investigator sites, vendors, studies, processes).
  • Lead inspection-readiness activities for studies and coordinate QA cross-functionally.
  • Establish relationships with study teams, vendors and external partners to support quality and inspections.
  • Maintain current knowledge of global GCP regulations and guidance and drive continuous improvement.
  • Coach and oversee junior R&D QA staff.

Skills

GCP QA
Audit leadership
Inspection readiness
Cross-functional collaboration
Quality assurance leadership

Education

Bachelor's degree in life science
Master's degree (preferred)

Job description

Overview:

The Senior Manager, R&D Quality Assurance independently performs the R&D QA Program Lead role for assigned clinical studies, providing Clinical Quality Assurance oversight in accordance with study protocols, company procedures, GCP requirements, and applicable local and international regulations. The role leads and supports quality oversight, audit, and inspection‑readiness activities and works cross‑functionally to identify, assess, mitigate, and accelerate quality and compliance risks. The Senior Manager also provides guidance and oversight to junior R&D QA staff, as applicable, and supports continuous improvement activities within R&D Quality Assurance. This is a hybrid role that can be based in Cambridge, MA; Philadelphia, PA; or Maidenhead, UK, with three days per week onsite.

Key Responsibilities:
  • Independently perform the R&D QA Program Lead role for assigned clinical studies, providing Clinical Quality Assurance oversight in accordance with study protocols, company procedures, GCP requirements, and applicable local and international regulations, with escalation to the GCP QA Director as appropriate.
  • Provide quality oversight for assigned clinical studies, including identification, assessment, mitigation, and escalation of quality and compliance risks and support for the investigation and resolution of Quality Events and CAPAs.
  • Lead and support GCP audit activities, including investigator site, vendor, study, and process audits, as applicable, and ensure audit observations and associated corrective and preventive actions are appropriately addressed.
  • Lead inspection‑readiness activities for assigned clinical studies, including coordination of QA and cross‑functional activities, identification and mitigation of potential inspection risks, and preparation for FDA, EMA, PMDA, and other Health Authority inspections.
  • Establish and maintain effective working relationships with internal Alnylam Expertise Area leads, study teams, vendors, and external partners to support study quality, compliance and inspection‑readiness activities.
  • Maintain current knowledge of applicable global GCP regulations, regulatory guidance, and industry practices and support continuous improvement of R&D QA processes, procedures and tools, as applicable.
  • Provide guidance, coaching and oversight to assigned junior R&D QA staff, as applicable, to support effective execution of assigned activities and continued development.
Qualifications:
  • Bachelor's degree, preferably life science (technology, biological science, pharmacy, or other health related discipline preferred) or equivalent qualification or clinical research experience. Master's degree in a science, technology or industry related discipline, preferred.
  • Seven years' experience in GCP Quality Assurance, or similar experience working in GCP and clinical trial that support pharmaceutical development.
  • Experience in overseeing late phase clinical trials.
  • Experience in leading audits preferred.
  • Experience supporting and leading inspections readiness efforts and direct inspection experience.
  • Extensive experience working with different Quality Assurance functions, knowledge of Auditing, Clinical Supply Chain, Clinical Operations, Monitoring, Regulatory Affairs, Clinical Research, Drug Safety, Data Management, Programming and Statistics.
  • Strong working knowledge & knowledge of how to interpret GCP regulations as well as industry guidance (e.g., FDA, EMA, and other national agencies).
About Alnylam:

Alnylam Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare and more prevalent diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach to treating diseases at their genetic source by "interfering" with mRNA that cause or contribute to disease. Since our founding in 2002, Alnylam has led the RNAi Revolution and continues to turn scientific possibility into reality.

Our culture:

Our people-first culture is guided by our core values: fiercely innovative, open culture, purposeful urgency, passion for excellence, and commitment to people, and these values influence how we work and the business decisions we make. Thanks to feedback from our employees over the years, we've been fortunate to be named a top employer around the world. Alnylam is extremely proud to have been recognized as one of Science Magazine's Top Biopharma Employers, one of America's Most Responsible Companies for 2024 by Newsweek, a Fast Company Best Workplace for Innovators, and a Great Place to Work in Canada, France, Italy, Spain, Switzerland, and UK - among others.

Equal Employment Opportunity:

At Alnylam, we commit to an inclusive recruitment process and equal employment opportunity. We are dedicated to building an environment where employees can feel that they belong, can bring their authentic selves to work, and ach

Get your free, confidential resume review.

or drag and drop your file here.

Similar jobs

Similar jobs worth comparing

Senior Manager, R&D Quality Assurance
Senior Manager, R&D Quality Assurance

Alnylam Pharmaceuticals, Inc. • Maidenhead

Hybrid
GBP 110,000 - 150,000
Associate Director, Biostatistics
Associate Director, Biostatistics

Alnylam Pharmaceuticals, Inc. • Maidenhead

Hybrid
GBP 95,000 - 140,000
Sr. Manager, Regulatory Affairs
Sr. Manager, Regulatory Affairs

Alnylam Pharmaceuticals, Inc. • Maidenhead

On-site
GBP 90,000 - 120,000
Associate Director, Biostatistics
Associate Director, Biostatistics

Alnylam Pharmaceuticals, Inc. • Maidenhead

Hybrid
GBP 120,000 - 160,000
R&D QA Program Lead: Clinical Trials & Inspections
R&D QA Program Lead: Clinical Trials & Inspections

Alnylam • Maidenhead

Hybrid
GBP 95,000 - 130,000
Senior R&D QA Lead: Clinical Trials & Inspection Readiness
Senior R&D QA Lead: Clinical Trials & Inspection Readiness

Alnylam Pharmaceuticals, Inc. • Maidenhead

Hybrid
GBP 110,000 - 150,000
Director, Clinical Research- Benign Hematology
Director, Clinical Research- Benign Hematology

Alnylampharmaceuticals • Cambridge, Maidenhead

On-site
GBP 190,000 - 258,000
Director, Clinical Research- Benign Hematology
Director, Clinical Research- Benign Hematology

Alnylam • Maidenhead

On-site
GBP 90,000 - 180,000
Executive Director, Clinical Research - Neurodegeneration
Executive Director, Clinical Research - Neurodegeneration

Alnylam Pharmaceuticals, Inc. • Maidenhead

Hybrid
GBP 189,000 - 303,000
Senior Manager, Clinical Quality Assurance
Senior Manager, Clinical Quality Assurance

AbbVie • Maidenhead

On-site
GBP 90,000 - 120,000
Healthcare benefits
401(k) plan
Paid time off